“Designing Small-Molecule Allosteric Inhibitors of CYP2C19 to Prevent Clopidogrel Resistance in Patients With Specific Genetic Polymorphisms” (2025) Link Medical Journal, 3(2), p. e76. doi:10.61919/gsj6hy59.